GSK Vows To Cooperate With China On Bribery Allegations; Pledges Review Of All Transactions Related To Travel Agency Use
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline has pledged swift cooperation with Chinese authorities over allegations massive bribes were paid to boost drug sales and prices in China over several years.